<unk>  appears to be well tolerated. The most common side effects associated with its use were headache (although there was no significant difference between participants who took<unk>  and those given a placebo), nasal congestion, and muscle pain. In a six-month trial, common adverse effects were nausea, diarrhea, elevated blood levels of triglycerides, and upper respiratory infection—similar to those of lamivudine;<unk>  was not associated with abnormal lipase levels, bone marrow suppression, or liver and kidney toxicity. No patients in either study had to stop taking<unk>  because of side effects.
Apricitabine
Decitabine
Zalcitabine
Trifluridine
Pralatrexate
Trimetrexate
Brincidofovir
Rucaparib